What's it like having ESR1 mutation metastatic breast cancer treatment?

I'm a premenopausal woman with hormone-positive metastatic breast cancer that has an ESR1 mutation. My oncologist discussed second-line hormone therapy options with me, including treatments that induce menopause combined with hormone therapies. Some options like Orserdu (elacestrant) and Inluriyo (imlunestrant) specifically target the ESR1 mutation. These are designed for after first-line hormone therapy stops working. I'd love to connect with others who have a similar diagnosis and hear about your experiences with second-line treatments. • What has your journey with second-line hormone therapy been like? • If you have an ESR1 mutation, what insights or tips do you have about navigating treatment decisions?